Variables | Total population | Patients with diabetes | Patients without diabetes | ||||||
---|---|---|---|---|---|---|---|---|---|
Diabetes | Non-diabetes | P | Hs-CRP < 2 mg/L | Hs-CRP ≥ 2 mg/L | P | Hs-CRP < 2 mg/L | Hs-CRP ≥ 2 mg/L | P | |
(n = 1040) | (n = 1694) | (n = 564) | (n = 476) | (n = 812) | (n = 882) | ||||
Age, years | 65.3 ± 7.9 | 64.0 ± 10.4 | 0.001 | 65.3 ± 9.4 | 65.3 ± 10.0 | 0.769 | 63.6 ± 10.0 | 64.4 ± 10.7 | 0.052 |
Male | 719 (69.1) | 1328 (78.4) |  < 0.001 | 401 (71.1) | 318 (66.8) | 0.135 | 643 (79.2) | 687 (77.7) | 0.447 |
Smoking | 381 (36.6) | 771 (45.5) |  < 0.001 | 189 (33.5) | 192 (40.3) | 0.023 | 336 (41.4) | 435 (49.3) | 0.001 |
Hypertension | 776 (74.6) | 1062 (62.7) |  < 0.001 | 425 (75.4) | 351 (73.7) | 0.551 | 478 (58.9) | 584 (66.6) | 0.002 |
Dyslipidemia | 850 (81.7) | 1318 (77.8) | 0.014 | 456 (80.9) | 394 (82.8) | 0.191 | 617 (76.0) | 701 (79.5) | 0.084 |
CKD | 116 (11.2) | 144 (8.5) | 0.022 | 42 (7.4) | 74 (15.5) |  < 0.001 | 46 (5.7) | 98 (11.1) |  < 0.001 |
Prior MI | 50 (4.8) | 55 (3.2) | 0.039 | 16 (2.8) | 34 (7.1) | 0.001 | 28 (3.4) | 27 (3.1) | 0.653 |
Prior PAD | 40 (3.8) | 46 (2.7) | 0.100 | 19 (3.4) | 21 (4.4) | 0.384 | 18 (2.2) | 28 (3.2) | 0.226 |
Prior cerebrovascular disease | 157 (14.1) | 199 (11.7) | 0.012 | 66 (11.7) | 80 (16.8) | 0.018 | 93 (11.5) | 84 (9.5) | 0.195 |
SBP, mm Hg | 139 ± 22 | 137 ± 23 | 0.006 | 139 ± 21 | 139 ± 23 | 0.943 | 138 ± 21 | 137 ± 24 | 0.369 |
DBP, mm Hg | 80 ± 23 | 81 ± 13 | 0.005 | 79 ± 10 | 80 ± 32 | 0.707 | 81 ± 13 | 80 ± 14 | 0.282 |
Hs-CRP, mg/L | 2.1 (0.7–5.9) | 1.8 (0.8–5.6) | 0.116 | 0.8 (0.5–1.4) | 2.3 (0.8–5.9) |  < 0.001 | 0.8 (0.5–1.2) | 1.9 (0.7–5.1) |  < 0.001 |
WBC, 109/L | 7.78 ± 2.83 | 7.71 ± 2.57 | 0.849 | 7.41 ± 2.73 | 8.21 ± 2.90 |  < 0.001 | 7.33 ± 2.42 | 8.06 ± 2.66 |  < 0.001 |
FBG, mmol/L | 10.3 ± 5.0 | 6.0 ± 2.0 |  < 0.001 | 9.5 ± 4.8 | 11.3 ± 5.1 |  < 0.001 | 5.8 ± 1.7 | 6.3 ± 2.3 |  < 0.001 |
HbA1c, % | 8.5 ± 1.7 | 6.2 ± 1.2 | 0.007 | 8.3 ± 1.6 | 8.6 ± 1.8 | 0.042 | 6.2 ± 1.3 | 6.2 ± 1.2 | 0.315 |
TC, mmol/L | 4.86 ± 1.18 | 5.04 ± 1.25 | 0.031 | 4.81 ± 1.13 | 4.94 ± 1.25 | 0.392 | 4.84 ± 1.22 | 5.27 ± 1.25 |  < 0.001 |
Triglyceride, mmol/L | 2.13 ± 1.51 | 1.76 ± 1.15 |  < 0.001 | 2.05 ± 1.18 | 2.26 ± 1.92 | 0.773 | 1.62 ± 1.04 | 1.93 ± 1.25 |  < 0.001 |
HDL-C, mmol/L | 1.23 ± 0.31 | 1.24 ± 0.31 | 0.787 | 1.21 ± 0.30 | 1.26 ± 0.33 | 0.132 | 1.21 ± 0.30 | 1.27 ± 0.31 | 0.017 |
LDL-C, mmol/L | 2.85 ± 0.79 | 3.00 ± 0.89 | 0.011 | 2.82 ± 0.74 | 2.89 ± 0.87 | 0.716 | 2.87 ± 0.88 | 3.15 ± 0.88 |  < 0.001 |
Creatinine clearance, mL/min | 94 ± 29 | 89 ± 23 |  < 0.001 | 96 ± 27 | 91 ± 30 | 0.021 | 91 ± 21 | 88 ± 25 | 0.032 |
LVEF, % | 52.7 ± 9.2 | 54.2 ± 7.9 |  < 0.001 | 53.4 ± 8.8 | 51.8 ± 9.6 |  < 0.001 | 55.0 ± 7.2 | 53.4 ± 8.5 |  < 0.001 |
Acute coronary syndrome | 364 (35.0) | 604 (35.7) | 0.728 | 182 (32.3) | 182 (38.2) | 0.044 | 247 (30.4) | 357 (40.5) |  < 0.001 |
Revascularization in hospital | 937 (90.1) | 1559 (92.0) | 0.082 | 509 (90.2) | 428 (89.9) | 0.858 | 755 (93.0) | 804 (91.1) | 0.166 |
LMT involvement | 159 (15.3) | 218 (12.9) | 0.075 | 98 (17.4) | 61 (12.8) | 0.042 | 105 (12.9) | 113 (12.8) | 0.942 |
SYNTAX score | 26.1 ± 9.8 | 24.7 ± 9.6 | 0.013 | 25.9 ± 9.9 | 26.2 ± 10.1 | 0.614 | 24.5 ± 9.8 | 24.9 ± 9.9 | 0.257 |
DES used | 821 (78.9) | 1423 (84.0) | 0.001 | 450 (79.8) | 371 (77.9) | 0.467 | 702 (86.5) | 721 (81.7) | 0.008 |
In-hospital death | 14 (1.3) | 5 (0.3) | 0.001 | 5 (0.9) | 9 (1.9) | 0.161 | 2 (0.2) | 3 (0.3) | 0.722 |